Details for 2020216368
Up to date per 13.05.2026
Actions
Details for 2020216368
Granted/Registered
European Patent
04.08.2021 A
20.03.2024 B1
10.06.2011
US
201161495884 P
26.07.2011
US
201161511901 P
15.08.2011
US
201161523790 P
A61K 38/36 20060101AFI20210614BHEP
Owner
Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, OsakaJP
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
Scheiflinger, FriedrichMichelbeürngasse 4/17 1090 WienAT
Turecek, PeterWeidling Hauptstrasse 59g 3400 KlosterneuburgAT
Ewenstein, Bruce15 Claflin Path Brookline, MA Massachusetts 02445-4401US
Wong, Wing Yen101 Lombard St No. 405W San Francisco, CA California 94111US
Suiter, Tobias M.Rennweg 1b 35083 WetterDE
Information about Fees